|
![]() |
|
|
Norethindrone: profile and news
FDA Approves New Oral Contraceptive Loestrin 24 Fe (norethindrone ... Feb 20, 2006 FDA OKs Warner Chilcott's contraceptive Feb 20, 2006 FDA Approves EMEND(R) (aprepitant), in Combination with Other ... Jan 11, 2006 Menopause Society Postmenopausal Hormone Therapy and Breast Cancer ... Nov 17, 2005 Barr Confirms FTC Lawsuit Related to Generic Ovcon-35(R) License Nov 7, 2005 Chewable birth control pill approved Sep 13, 2005 FDA Safety Labeling Changes: Activella, Duramorph PF, Nutropin Sep 7, 2005 International Approvals: Adderall XR, Gynazole-1, Leuplin SR Aug 29, 2005 Scientist George Rosenkranz 06 Aug 2005 Chewable birth control pill approved Aug 4, 2005 Antares Pharma Unveils Proprietary Anti-Anxiety Transdermal Gel Jun 30, 2005 Hormone therapy market rallies Jun 16, 2005 Hormone therapy market rallies Jun 16, 2005 Effects of Low-Dose Hormone Therapy on Menopausal Symptoms, Bone ... Jun 9, 2005 News For Your Web Site Apr 19, 2005 Study Suggests Zonegran(R) (zonisamide) Capsules Are Not Likely to ... Apr 12, 2005 FDA Safety Labeling Changes: CombiPatch, Antidepressants Mar 23, 2005 Other information Indication For use as an oral contraceptive in the prevention of pregnancy. Pharmacology Norethindrone is a synthetic oral progestin. It is used for contraception or to treat such conditions as secondary amenorrhea, abnormal uterine bleeding, and endometriosis. As an oral contraceptive, norethindrone is available as either a single agent or in combination with an estrogen. Mechanism Of Action Progestins diffuse freely into target cells and bind to the progesterone receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH surge. Drug Category Contraceptives, Oral, Synthetic; Progestins; ATC:G03CA Brand Names/Synonyms Anhydrohydroxynorprogesterone; Anovulatorio; Anovule; Aygestin; Binovum; Brevicon; Brevinor; Brevinor 21; Brevinor 28; Brevinor-1 21; Brevinor-1 28; CCRIS 484; Camila; Ciclovulan; Conceplan; Conludaf; Conludag; Demulen; ENT; Errin; Estrinor; Ethinylnortestosterone; Ethynylmortestosterone; Ethynylnortestosterone; Gencept; Genora; Gestest; HSDB 3370; Jenest; Jenest-28; Levlen; Loestrin; Menzol; Microneth; Micronett; Micronor; Micronovum; Milli; Mini-Pe; Mini-Pill; Minovlar; Modicon; N.E.E.; NET; NSC-9564; Necon; Nelova; Neocon; Nodiol; Nor-Q.D.; Nor-Qd; Noraethisteronum; Noralutin; Norcept; Norcept-E; Norcolut; Nordette; Noresthisterone; Norethadrone; Norethin; Norethin 1/35 E; Norethin 1/50 M; Norethindrone; Norethindrone Acetate; Norethindrone Norethisterone; Norethisteron; Norethisterone; Norethisterone [Progestins]; Norethisteronum [Inn-Latin]; Norethyndron; Norethynodron; Norethynodrone; Noretisterona [Inn-Spanish]; Noretisterone [Dcit]; Norfor; Norgestin; Noriday; Noriday 28; Norimin; Norinyl; Norlestrin; Norlutate; Norluten; Norlutin; Norluton; Normapause; Norpregneninlone; Norpregneninolone; Norpregneninotone; Orlest; Ortho 1 35; Ortho 7 7 7; Ortho-Novum; Ortho-Novum 1 35; Ortho-Novum 1 50; Ortho-Novum 7 7 7; Ovcon; Ovral; Ovrette; Ovysmen; Ovysmen 0.5 35; Ovysmen 1 35; Palonyl; Perovex; Primolut N; Primolut-N; Proluteasi; SC 4640; Synphase; Synphasic 28; Tri-Levlen; Tri-Norinyl; Triella; Trinovum; Trinovum 21; Utovlan; Utovlar Dosage Forms TABLET Absorption Absolute oral bioavailability approximately 64% Interactions Interactions for Norethindrone: The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin. No significant interaction has been found with broad-spectrum antibiotics. Chemical IUPAC Name 17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one Chemical Formula C20H26O2 Half Life 7 hours Drug Type Approved Drug # Accession No APRD00679 CAS Registry Number 68-22-4 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |